Forbion, a prominent biotech investor, raises $2.6B for a pair of venture funds

T2Covered by 1 source · first reported by BioPharma Dive / Healthcare Dive / MedTech Dive at 06 Oct, 18:04 UTC

The fundraise is the firm’s largest to date, providing a lift for a European biotech industry that’s fallen further behind its counterparts in the U.S. and China.

science

Sources

• T2Forbion, a prominent biotech investor, raises $2.6B for a pair of venture fundsBioPharma Dive / Healthcare Dive / MedTech Dive06 Oct, 18:04